Cite
HARVARD Citation
Jung, K. et al. (n.d.). 1956 Safety and tolerability of subcutaneous trastuzumab for HER2-positive early breast cancer in patients with lower body weight and in Asian patients: SafeHer Phase III study subgroup analyses. European journal of cancer. pp. S318-. [Online].